XML 91 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity Investments - Equity Investments Table (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year $ 1,224,813 $ 1,285,717  
Other-than-temporary impairment expense (11,805) (29,399)  
Equity income, net 204,645 226,750 $ 237,518
Contributions 4,435 19,388 128,393
Distributions (213,516) (246,637) (234,572)
Distributions in excess of cumulative earnings (41,385) (32,160) (30,256)
Divestitures   1,154  
Balance at end of period 1,167,187 1,224,813 1,285,717
Fort Union [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 0 (610)  
Other-than-temporary impairment expense   0  
Equity income, net   (544)  
Contributions   0  
Distributions   0  
Distributions in excess of cumulative earnings   0  
Divestitures   1,154  
Balance at end of period   0 (610)
White Cliffs [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 45,623 45,877  
Other-than-temporary impairment expense 0 0  
Equity income, net 780 5,474  
Contributions 0 993  
Distributions (199) (4,892)  
Distributions in excess of cumulative earnings (5,451) (1,829)  
Divestitures   0  
Balance at end of period 40,753 45,623 45,877
Rendezvous [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 28,198 32,964  
Other-than-temporary impairment expense 0 0  
Equity income, net (2,155) 52  
Contributions 0 0  
Distributions (1,103) (1,994)  
Distributions in excess of cumulative earnings (2,865) (2,824)  
Divestitures   0  
Balance at end of period 22,075 28,198 32,964
Mont Belvieu JV [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 98,874 103,036  
Other-than-temporary impairment expense 0 0  
Equity income, net 33,991 25,913  
Contributions 0 0  
Distributions (33,944) (25,951)  
Distributions in excess of cumulative earnings (2,193) (4,124)  
Divestitures   0  
Balance at end of period 96,728 98,874 103,036
Texas Express Gathering [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 16,661 18,199  
Other-than-temporary impairment expense 0 0  
Equity income, net 4,508 4,483  
Contributions 0 0  
Distributions (4,533) (4,504)  
Distributions in excess of cumulative earnings (520) (1,517)  
Divestitures   0  
Balance at end of period 16,116 16,661 18,199
Texas Express Pipeline [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 195,189 203,556  
Other-than-temporary impairment expense 0 0  
Equity income, net 36,547 36,351  
Contributions 0 0  
Distributions (36,797) (39,655)  
Distributions in excess of cumulative earnings (6,014) (5,063)  
Divestitures   0  
Balance at end of period 188,925 195,189 203,556
Front Range Pipeline [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 199,881 207,782  
Other-than-temporary impairment expense 0 0  
Equity income, net 38,280 37,736  
Contributions 750 3,670  
Distributions (38,275) (39,254)  
Distributions in excess of cumulative earnings (4,004) (10,053)  
Divestitures   0  
Balance at end of period 196,632 199,881 207,782
Whitethorn LLC [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 156,729 161,665  
Other-than-temporary impairment expense 0 0  
Equity income, net 4,969 35,725  
Contributions 349 428  
Distributions (6,428) (41,070)  
Distributions in excess of cumulative earnings (5,929) (19)  
Divestitures   0  
Balance at end of period 149,690 156,729 161,665
Cactus II [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 173,921 172,165  
Other-than-temporary impairment expense 0 0  
Equity income, net 18,237 22,193  
Contributions 3,336 13,645  
Distributions (18,404) (31,982)  
Distributions in excess of cumulative earnings (5,796) (2,100)  
Divestitures   0  
Balance at end of period 171,294 173,921 172,165
Saddlehorn [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 111,717 112,855  
Other-than-temporary impairment expense 0 0  
Equity income, net 30,878 26,255  
Contributions 0 0  
Distributions (31,403) (27,393)  
Distributions in excess of cumulative earnings (751) 0  
Divestitures   0  
Balance at end of period 110,441 111,717 112,855
Panola [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 20,867 21,783  
Other-than-temporary impairment expense 0 0  
Equity income, net 2,188 2,047  
Contributions 0 0  
Distributions (2,188) (2,047)  
Distributions in excess of cumulative earnings (823) (916)  
Divestitures   0  
Balance at end of period 20,044 20,867 21,783
Mi Vida [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 55,031 57,807  
Other-than-temporary impairment expense 0 0  
Equity income, net 10,491 10,764  
Contributions 0 0  
Distributions (10,596) (11,563)  
Distributions in excess of cumulative earnings (3,163) (1,977)  
Divestitures   0  
Balance at end of period 51,763 55,031 57,807
Ranch Westex [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 18,898 46,678  
Other-than-temporary impairment expense (11,805) (29,399)  
Equity income, net 12,407 12,127  
Contributions 0 0  
Distributions (15,657) (9,802)  
Distributions in excess of cumulative earnings (2,864) (706)  
Divestitures   0  
Balance at end of period 979 18,898 46,678
Red Bluff Express [Member]      
Schedule of Equity Method Investments [Line Items]      
Balance at beginning of year 103,224 101,960  
Other-than-temporary impairment expense 0 0  
Equity income, net 13,524 8,174  
Contributions 0 652  
Distributions (13,989) (6,530)  
Distributions in excess of cumulative earnings (1,012) (1,032)  
Divestitures   0  
Balance at end of period $ 101,747 $ 103,224 $ 101,960